Upon the recognition of tumor cells, NK-cell activation occurs through the interaction of NKG2D receptors on the surface of NK cells with ULBP ligands and the MHC class I chain-associated proteins MICA and MICB on the surface of tumor cells [123]. This evidence concerns the gene MICB and neoplasm.